Skip to Content
Minerva Neurosciences Reports Second Quarter 2020 Financial Results and Business Updates
Minerva Neurosciences to Report Second Quarter 2020 Financial Results and Business Updates on August 3, 2020
Minerva Neurosciences Opts Out of Agreement With Janssen for Seltorexant
Minerva Neurosciences Exercises Right to Opt Out of Agreement With Janssen for Seltorexant (MIN-202)
Thinking about buying stock in Remark Holdings, Heat Biologics, Minerva Neurosciences, Carnival Corp, or Las Vegas Sands?
REVISED WEBCAST & CALL INFORMATION: Minerva Neurosciences to Hold Webcast and Call With Key Opinion Leaders to Present Additional Analyses From Phase 3 Trial of Roluperidone (MIN-101) for Treatment of Negative Symptoms in Schizophrenia
Minerva Neurosciences' stock plummets after schizophrenia treatment disappoints in phase 3 study
Minerva Neurosciences Announces Results From Phase 3 Trial of Roluperidone (MIN-101) for Treatment of Negative Symptoms in Schizophrenia
Thinking about buying stock in TOP Ships, General Electric, Oncolytics Biotech, Trevena, or Minerva Neurosciences?
Thinking about trading stocks or options in Moderna, Carnival Corp, Minerva Neurosciences, Apple, or Nvidia?